Perceptions of heart failure diagnosis and management: Comparison between clinical cardiologists and family doctors;Percepções sobre diagnóstico e manuseio da insuficiência cardíaca: comparação entre cardiologistas clínicos e médicos de família

Arquivos Brasileiros de Cardiologia

Volumn 87, Issue 2, 2006, Pages 167-173

  Tavares, Leandro Reis ^a,b   Cocca Velarde, Luis Guilhermo ^a   De Miranda, Verônica Alcoforado ^a   Mesquita, Evandro Tinoco ^a  

^a FLUMINENSE FEDERAL UNIVERSITY   (Brazil)

^b NONE   (Brazil)

Author keywords

Diagnosis; Heart failure; Management

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; SPIRONOLACTONE;

ARTICLE; CARDIOLOGIST; CLINICAL FEATURE; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; DISEASE SEVERITY; DYSPNEA; ECHOCARDIOGRAPHY; EDEMA; FATIGUE; GENERAL PRACTITIONER; HEART FAILURE; HUMAN; MORTALITY; QUALITATIVE ANALYSIS; QUESTIONNAIRE; SYSTOLIC BLOOD PRESSURE;

EID: 33748435472     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/s0066-782x2006001500015     Document Type: Article

References (28)

1. Cowie MR, Mosterd A, Wood DA, et al. The epidemiology of heart failure. Eur Heart J. 1997; 18: 208-25.
2. Senni M, Tribouilloy CM, Rodeheffer RJ, et al. Congestive heart failure in the community: trends in incidence and survival in a 10-year period. Arch Intern Med. 1999; 159: 29-34.
3. Stewart AL, Greenfield S, Hays RD, et al. Functional status and well-being of patients with chronic conditions. The Outcomes Study. J Am Med Assoc. 1989; 262: 907-13.
4. Ileana PL. Risks and benefits of a multidrug approach to mild-to-moderate heart failure. Am J Med. 2001; 110(7A): 63s-67s.
5. Ledwidge M, Barry M, Cahill J, Ryan E, Maurer B, Ryder M, et al. Is multidisciplinary care of heart failure cost-beneficial when combined with optimal medical care? Eur J Heart Fail. 2003; 5: 381-9.
6. Anderson B, Waagstein F. Spectrum and outcome of congestive heart failure in a hospitalized population. Am Heart J. 1993; 126: 632-40.
7. Hobbs FDR, Kenkre JE, Roalf AK, Davis RC, Hare R, Davies MK. Impact of heart failure and left ventricular systolic dysfunction on quality of life. Eur Heart J. 2002; 23: 1867-76.
8. Al-Kaade S, Hauptman PJ. Health-related quality of live mesurament in heart failure: challenges for the new millennium. J Card Fail. 2001; 7 (2): 194-201.
9. Schocken DD, Arieta MI, Leaverton PE, et al. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol. 1992; 20: 301-6.
10. The Consensus Trial Study Group - Effects os enalapril on mortality in severe congestive heart failure; results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med. 1987; 316: 1429-35.
11. Pfeffer MA, Braunwald E, Moye LA, Flaker GC. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE investigators. N Engl J Med. 1992, 327: 669.
12. Packer M, Fowler MB, Roecker EB, Coats AJ, DeMets DL. Effect of carvedilol on the morbidity of patients with severe chronic heart failure: results of the carvedilol prospective randomized cumulative survival (COPERNICUS) study. Circulation. 2002; 106: 2194-9.
13. Fowler MB, Montserrat VL, Oster G, et al. Influence of carvedilol on hospitalizations in heart failure: incidence, resource utilizations and costs. J Am Coll Cardiol. 2001; 37: 1692-9.
14. The Randomized Aldactone Evaluation Study Group. The effect os spironolactone on morbidity and mortality in patients with severe heart failure. N Engl J Med. 1999; 341: 709-17.
15. II Diretrizes para o diagnóstico e tratamento da Insuficiência Cardíaca da Sociedade Brasileira de Cardiologia. Arq Bras Cardiol. 2002; 79 (Sup IV): 1-30.
16. Paker M, Poole-Wilson PA, Armstrong PW, et al. Comparative effects of low doses and high doses of angiotensin converting-enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure. Circulation. 1999; 100: 2312-18.
17. Bozkurt B, Agoston I, Knowlton AA. Complications of inappropriate use of spironolactone in heart failure: when an old medicine spirals out of new guidelines. J Am Coll Cardiol. 2003; 41 (2): 211-14.
18. Wheeldon NM, McDonald TM, Flucker CJ, McKendrick AD, McDevitt DO, Struthers AD. Echocardiography in chronic heart failure in the community. Q J Med. 1993; 86: 17-23.
19. Reis SE, Holubkov R, Edmundowicz D, McNamara DM, Zell KA, Detre KM, et al. Treatment of patients admitted to the hospital with congestive heart failure: specialty-related disparities in practice patterns and outcomes. J Am Coll Cardiol. 1997; 30 (3): 733-8.
20. Rutten FH, Diederick EG, Hoes AW. Diagnosis and management of heart failure: a questionnaire among general practitioners and cardiologists. Eur J Heart Fail. 2003; (5): 345-8.
21. Harjai KJ, Boulos LM, Samrt FW, Turgut T, Krousel-Wood MA, Stapleton DD, et al. Effects of caregiver specialty on cost and clinical outcomes following hospitalization for heart failure. Am J Cardiol. 1998; 82: 82-5.
22. Lowe J, Candlish P, Henry D, Wlodarcyk J, Fletcher P. Specialist or generalist care? A study of the impact of a selective admitting policy for patients with cardiac failure. I J Q Health Care. 2000; 12 (4): 339-45.
23. Indrisdason OS, Coffman CJ, Oddone EZ. Is specialty care associated with improved survival of patients with congestive heart failure? Am Heart J. 2003; 145: 300-9.
24. Hobbs FDR, Jones MI, Allan TF, Wilson S, Tobias R. European survey of primary care physician perceptions on heart failure diagnosis and management (EURO-HF). Eur Heart J. 2000; 21: 1877-87.
25. Khunti K, Hearnshaw H, Baker R, Grimshaw G. Heart failure in primary care: qualitative study of current management and perceived obstacles to evidence-based diagnosis and management by general practitioners. Eur J Heart Fail. 2002; 4: 771-7.
26. Edep ME, Shah NB, Tateo IM, Massie BM. Differences between primary care physicians and cardiologists in management of congestive heart failure: relation to guidelines. J Am Coll Cardiol. 1997; 30: 518-26.
27. Houghton AR, Cowley AJ. Why are angiotensin converting enzyme inhibitors underutilized in the treatment of heart failure by general practitioners? I J Cardiol. 1997; 59: 7-10.
28. Rutten FH, Diederick EG, Hoes AW. Differences between general practioners and cardiologists in diagnosis and management of heart failure: a survey in every-day practice. Eur J Heart Fail. 2003; (5): 337-344.